36E79726Q0004.docx
DOCX document 20 KB Posted
- Attached to
- 6505--Droxidopa Capsules (VA-27-00007975)
- Solicitation number
- 36E79726Q0004
About this file
This is a Sources Sought Notice and market research questionnaire for Droxidopa Capsules issued by the Department of Veterans Affairs National Acquisition Center. The procurement targets three dosage strengths: 100MG, 200MG, and 300MG capsules in 90-count bottles, with estimated annual usage of 6,160, 3,587, and 3,738 bottles respectively. This market research will inform a forthcoming national mandatory requirements contract serving the Department of Veterans Affairs, Department of Defense, Indian Health Service, Bureau of Prisons, and Federal Health Care Center. The awarded contractor will be the sole supplier for ordering activities across these agencies, and competitors offering the same or similar products will be excluded from ordering.
Interested parties must respond by September 4, 2026 at 2:30 PM Central Time with answers to specific capability questions. Minimum requirements include possession of a unique eleven-digit National Drug Code (NDC) with the offeror's labeler code as the first five digits, ability to provide manufacturer commitment letters if not the manufacturer, and current business-to-business agreements with Pharmaceutical Prime Vendors serving VA and DoD ordering activities. Additional requirements address small business status, domestic content or Trade Agreements Act compliance, packaging specifications (120cc minimum volume bottles with child-proof closures meeting specific dimensional requirements for 5.25" x 2" labels), and ability to begin supply within 60 days of award. The VA seeks a base year plus up to four option years to provide long-term supply continuity. Contract performance will occur at the VA's National Acquisition Center in Hines, Illinois.
View the file
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Sources Sought Notice Sources Sought Notice
| SUBJECT* |
| Droxidopa Capsules (VA-27-00007975) |
GENERAL INFORMATION
| CONTRACTING OFFICE’S ZIP CODE* |
| 60141 |
| SOLICITATION NUMBER* |
| 36E79726Q0004 |
| RESPONSE DATE/TIME/ZONE |
| 09-04-2026 2:30pm CENTRAL TIME, CHICAGO, USA |
| ARCHIVE |
| 30 DAYS AFTER THE RESPONSE DATE |
| RECOVERY ACT FUNDS |
| N |
SET-ASIDE
| PRODUCT SERVICE CODE* |
| 6505 |
| NAICS CODE* |
| 325412 |
| CONTRACTING OFFICE ADDRESS |
| Department of Veterans Affairs |
OPAL / National Acquisition Center Building 37 1st Avenue, One Block North of Cermak Hines, IL 60141
POINT OF CONTACT*
Contract Specialist Andrew Cazares andrew.cazares@va.gov (708)786-4990
PLACE OF PERFORMANCE
| ADDRESS |
| Department of Veterans Affairs |
OPAL / National Acquisition Center
Building 37
1st Avenue, One Block North of Cermak
Hines IL
| POSTAL CODE |
| 60141 |
COUNTRY
ADDITIONAL INFORMATION
AGENCY’S URL
URL DESCRIPTION
| AGENCY CONTACT’S EMAIL ADDRESS |
| andrew.cazares@va.gov |
| EMAIL DESCRIPTION |
| Contract specialists email |
DESCRIPTION
MARKET RESEARCH QUESTIONNAIRE – Droxidopa Capsules
Company Name: _________________________
I am conducting market research for the procurement of Droxidopa Capsules, for the Department of Veterans Affairs (VA), Department of Defense (DoD), Indian Health Service (IHS), Bureau of Prisons (BOP), and Federal Health Care Center (FHCC). This procurement will result in a national mandatory requirements contract for the above agencies. Other companies with the same/similar product will be blocked out for ordering; therefore it is our goal to award lower than FSS/Open Market prices on the resultant national contract based on purchases of a committed volume. These products will be awarded in the aggregate for all strengths and sizes for the base year and all option years included in the solicitation. Please provide a response to the following:
1. Is your Company able to meet the following minimum requirements:
a. National Drug Code (NDC): Offerors shall provide a separate and distinct eleven-digit NDC number unique to the offeror (e.g., 00012-3456-78) for each product proposed. The first five numbers of the eleven-digit NDC number for each product proposed shall identify the offeror. Additionally, the successful offeror/contractor’s label with its unique NDC shall be the only label on the product. Contractors shall not affix their label over another label on the product. Does your company have a unique NDC (Labeler Code)? _____________
b. If the offeror is not the manufacturer of the offered items, the offeror shall submit a letter of commitment from the manufacturer to the offeror which will assure the offeror a source of supply sufficient to satisfy the Government's requirements for the contract period. Name of Manufacturer: _________________
Would you be able to provide a letter of commitment from the manufacturer of the offered drug? _____________
c. Pharmaceutical Prime Vendor: All Ordering Activities under the Department of Veterans Affairs and Department of Defense acquire their pharmaceutical requirements through their Pharmaceutical Prime Vendor Program (PPV). The contractor shall ensure that chargeback agreements with the PPVs have been executed with sufficient time to permit the PPVs to begin timely distribution of Government orders, if an award is made. Does your company currently have a business-to-business agreement with the PPVs? _________
2. Under NAICS code 325412, is your company size (check one):
Large Business ______ Small Business ______
3. If a small business, does your company manufacture (measure, weigh, mix, and compound) at least 50% of the product offered? ___________
4. If your company is not the manufacturer, is the manufacturer a small business concern, as defined in FAR Part 2 with an active SAM registration? ___________
5. Is the offered end product U.S-made, as defined in FAR Part 25? ___________
6. If not, if the offered product an end product of a Trade Agreements Act designated country, as defined in FAR Part 25? _________
7. Can your company meet the following product, bottle size and usage? Please indicate any details or comments.
| Item |
| Description |
| Package Size (Capsules per Bottle) |
| Total Estimated Annual Usage (Bottles) |
| 1 |
| Droxidopa 100MG Capsules, ORAL |
| 90 |
| 6,160 |
| 2 |
| Droxidopa 200MG Capsules, ORAL |
| 90 |
| 3,587 |
| 3 |
| Droxidopa 300MG Capsules, ORAL |
| 90 |
| 3,738 |
8. Is your Company interested in submitting a response to a solicitation?________
9. As this is a national standardized contract, our preference is for a base plus four option years to provide our customers with continuity and consistency of product by allowing for long-term committed purchases of your product. If interested, please indicate base year and how many option periods, not to exceed four._________________
10. If an award were to be made based on the above requirements, would your company be able to begin supplying the product in the estimated quantities within 60 days of the contract award date?
11. If your company is not interested in participating, please respond with the reason why. This aids our market research for future procurements.
12. VA intends to require in the solicitation that proposed products are in unit of use package sizes for all line items (90-count bottles). VA defines unit of use package sizes as follows: Unit of use package sizes must contain a child proof closure (safety cap) and a bottle with a minimum required size of 120cc volume. The safety cap must not exceed the diameter of the bottle. The bottle must have a cylindrical body and minimum of 5.75” circumference. The bottle must fit a label with a dimension of 5.25” x 2”. The 0.5” additional space is required to keep the bar code exposed and/or allow for the display of the expiration date and lot number. Please indicate if your company can provide the products above meeting these packaging requirements.
13. If your company could supply the products in this solicitation in 90-count bottles, but could not meet the unit of use requirements outlined above, please use the space below to indicate the reason and any details. This information is important as it helps the Government consider possible product issues when developing the solicitation.
If you could provide your responses by next Friday, September 4, 2026, it would be greatly appreciated. Please contact me at Andrew.Cazares@va.gov if you have any questions.
| *= Required Field |
| Sources Sought Notice |
Sources Sought Notice
File details come from the government source that posted it. Updated .